ClinConnect ClinConnect Logo
Search / Trial NCT03981640

Neural Control of Kidney Blood Flow During Exercise in African American Adults

Launched by UNIVERSITY OF MASSACHUSETTS, BOSTON · Jun 6, 2019

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Exercise Cold Stress Mental Stress

ClinConnect Summary

This clinical trial is studying how exercise affects blood flow to the kidneys in African American adults. Researchers want to understand if the body's response to exercise is different in this group compared to White adults, particularly focusing on the sympathetic nervous system, which is responsible for our fight-or-flight reactions. They believe that during exercise, African American adults may experience stronger kidney blood vessel constriction, which could lead to long-term health issues such as heart and kidney disease. By observing how the kidneys respond during exercise and other stress tests, the study aims to uncover important information that could help reduce the risk of these diseases in the future.

To participate in this trial, individuals must be healthy, self-identifying as either African American or White, and born in the United States. They should be physically active for at least 20 minutes several times a week but should not be training for competitions. Participants will undergo tests that measure blood flow and blood pressure while they exercise and during other stress-inducing activities. It’s important to note that individuals with certain health conditions, like high blood pressure or diabetes, or those who are pregnant, cannot participate. This study is a great opportunity for eligible individuals to contribute to research that could benefit their community's health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-report as either African American or White racial identity
  • Born in United States
  • Both biological parents identify as same racial identity as participant
  • Recreationally active (participating in physical activity for at least 20 minutes per day, at least three times per week, but not training for competitive events)
  • Fluent in English
  • Exclusion Criteria:
  • Hispanic or Latino
  • Females who are pregnant or lactating
  • Cardiovascular or renal disease
  • Hypertension (blood pressure of more than or equal to 130/80 mmHg)
  • Diabetes
  • Obesity (body mass index of more than or equal to 30 kg/m2)
  • Smoker/Tobacco user
  • Acute medical conditions
  • Taking prescribed cardiovascular, antihypertensive, or renal medications

About University Of Massachusetts, Boston

The University of Massachusetts, Boston, is a leading academic institution dedicated to advancing healthcare research and innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources, expert faculty, and collaborative environment to explore new medical therapies and interventions. Committed to improving public health outcomes, UMass Boston fosters rigorous scientific inquiry and ethical standards in its research endeavors, aiming to translate findings into practical applications that benefit diverse populations. Through partnerships with healthcare providers and community organizations, the university plays a vital role in addressing critical health challenges and enhancing the quality of care.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Rachel C Drew, PhD

Principal Investigator

University of Massachusetts, Boston

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials